0001209191-22-059702.txt : 20221205
0001209191-22-059702.hdr.sgml : 20221205
20221205163023
ACCESSION NUMBER: 0001209191-22-059702
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221202
FILED AS OF DATE: 20221205
DATE AS OF CHANGE: 20221205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferrara Robert L
CENTRAL INDEX KEY: 0001792987
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 221445316
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE, SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-02
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0001792987
Ferrara Robert L
C/O PHIO PHARMACEUTICALS CORP.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
1
0
0
0
Common stock, $0.0001 par value
2022-12-02
4
P
0
5000
0.4082
A
30000
D
This transaction was executed in multiple trades at prices ranging from $0.4075 to $0.4089. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes shares of common stock underlying unvested restricted stock units.
Caitlin Kontulis, attorney-in-fact
2022-12-05